Search

everythinglearnresearchcommunity

for

Search:↓

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

UC.145 may be a new biomarker for predicting gastric cancer.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Higher PHGDH levels cause unusual melanin buildup in hair follicles.

Targeting the PGD2-DP2 pathway may help treat hair loss.

CPDC offers significant cost savings on men's health medications compared to Medicare and GoodRx.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Male and female hair loss have different genetic causes.

PRP can improve hair growth in androgenetic alopecia, but results vary.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

High TSPEAR levels in colorectal cancer predict worse outcomes.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Upadacitinib effectively treats pyoderma gangrenosum.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Higher EGF levels are linked to more severe alopecia areata.

PRP therapy effectively improves hair density and reduces hair loss in androgenetic alopecia.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

General surgeons in India need to manage peripheral arterial disease due to a shortage of vascular surgeons.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

PRP improves hair transplant results in androgenetic alopecia patients.